Compound information
- Natural Products
- ZC834161
- Molecular Formula
- C14H19NO4
- Molecular Weight
- 265.131408088 g/mol
- Structure
-
- IUPAC Name
- methyl (2S)-2-(benzyloxycarbonylamino)-3-methyl-butanoate
- InChI
- InChI=1S/C14H19NO4/c1-10(2)12(13(16)18-3)15-14(17)19-9-11-7-5-4-6-8-11/h4-8,10,12H,9H2,1-3H3,(H,15,17)/t12-/m0/s1
- InChI Key
- LKTVCURTNIUHBH-LBPRGKRZSA-N
- SMILES
- COC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C
- Source
- ZINC000002567684
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 64.63 Å2 | LogP | 2.568 |
LogS | -2.678 | LogD | 2.604 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.15 | Pgp substrate | 0.005 |
HIA | 0.966 | F20 % | 0.994 |
F30 % | 0.957 | Caco-2 | -4.532 |
MDCK | -4.552 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.077 | PPB | 83.244 |
VD | 0.94 | Fu | 1.165 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.245 | CYP1A2 substrate | 0.699 |
CYP2A6 substrate | 0.496 | CYP2B6 substrate | 0.655 |
CYP2C19 inhibitor | 0.879 | CYP2C19 substrate | 0.935 |
CYP2C8 substrate | 0.842 | CYP2C9 inhibitor | 0.222 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.027 |
CYP2D6 substrate | 0.6 | CYP2E1 substrate | 0.398 |
CYP3A4 inhibitor | 0.03 | CYP3A4 substrate | 0.734 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.717 | CL | 6.007 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.048 | Hepatotoxicity | 0.795 |
Mutagenicity | 0.59 | Rat Oral Acute Toxicity | 0.005 |
FDAMDD | 0.075 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.007 | Eye Corrosion | 0.006 |
Eye Irritation | 0.106 | Respiratory Toxicity | 0.004 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.859 | IGC50 | 3.031 |
LC50FM | 3.904 | LC50DM | 5.15 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.085 | NR-AR-LBD | 0.178 |
NR-AhR | 0.003 | NR-Aromatase | 0.049 |
NR-ER | 0.224 | NR-ER-LBD | 0.373 |
NR-PPAR-gamma | 0.161 | SR-ARE | 0.014 |
SR-ATAD5 | 0.381 | SR-HSE | 0.105 |
SR-MMP | 0.01 | SR-p53 | 0.016 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.